Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Biopharmaceuticals

Challenges and Opportunities
BuchGebunden
278 Seiten
Englisch
CRC Presserschienen am08.12.2020
This book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies.mehr
Verfügbare Formate
BuchGebunden
EUR232,50
E-BookEPUB0 - No protectionE-Book
EUR237,99
E-BookPDF0 - No protectionE-Book
EUR237,99

Produkt

KlappentextThis book highlights how traditional microbial process technology has been upgraded for the production of biologic drugs, and evolution of manufacturing process to meet the global market demand with quality products under the guide lines of internally recognised regulatory bodies.
Details
ISBN/GTIN978-0-8153-4777-4
ProduktartBuch
EinbandartGebunden
FormatGenäht
Verlag
Erscheinungsjahr2020
Erscheinungsdatum08.12.2020
Seiten278 Seiten
SpracheEnglisch
MasseBreite 155 mm, Höhe 239 mm, Dicke 18 mm
Gewicht476 g
Artikel-Nr.56655141
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Biopharmaceutical- A New Confront. Biopharmaceutical Production. Transitioning from Pharmaceutical to Biopharmaceutical. Biopharmaceutical from Animal cells. Plant Biomolecules and Therapeutic. Biosimilar. Biopharmaceutical Supply Chain Management.mehr

Autor

Dr. Basanta Kumara Behera served as professor and director of biotechnology at three distinguished Indian universities, where he had been regularly associated with teaching and research at post graduate level courses on the topic related to Microbial processing technology, fermentation technology, biotechnology, genetic engineering, protein engineering, and therapeutic proteins. In 2009 he joined a MNS company as adviser for speciality chemicals production and drug design through microbial process technology. Prof. Behera is associated with national and international repute companies as technical adviser for the production of biopharmaceuticals under cGMP norms. Dr Behera has credit of being authored books published/in Springer Verlag, Germany; Elsevier USA; CABI, UK.